Cyprus: Manual Of Industrial Property



[A] Kinds of Patents

– National patent

– European patent

[B] Duration of Patents

– 20 years from the date of filing

[C] Patentable / Not Patentable

– To be patentable, an invention must be new, involve an inventive step and be applicable in industry.

– The exceptions of rule 39 PCT apply.

– Also not patentable are computer programs; processes for cloning human beings; processes for modifying the germ line genetic identity of human beings; uses of human embryos for industrial or commercial purposes.

– Processes for modifying the genetic identity of animals, which are likely to cause them suffering without any substantial medical benefit to man or animal, and also animals resulting from such processes.

[D] Novelty

– Absolute novelty is required.

[E] Requirements and Procedure

– Filing language: Any

– Language of translation: Greek

– Time limit for filing translation: 4 months from filing

– Patent applications are examined as to form only but not as to substance.

[F] Specific Aspects of Regional Patents

– Validation of European Patents in Cyprus is possible.

[G] Specific Aspects of International Patent Applications (PCT)

– The only way to extend a PCT international application to Cyprus is by way of a European Patent validated in Cyprus.

[H] Governmental Websites


[A] Conventions and Legislation

[1] Conventions

– Paris Convention (International Union), 1883–1967 (Cyprus is bound by the Stockholm text of 1967 since 3 April 1984);

– Hague Convention Abolishing the Requirement of Legalization for Foreign Public Documents, 1961, since 30 April 1973;

– Convention Establishing the World Intellectual Property Organization (hereinafter 'WIPO Convention'), 1967, since 26 October 1984;

– Patent Cooperation Treaty (PCT), 1970, since 1 April 1998;

– European Patent Convention, 1973, since 1 April 1998;

– WTO TRIPS Agreement, since 30 July 1985;

– Budapest Treaty on the International Recognition of the Deposit of Microorganisms for the Purposes of Patent Procedure;

– EU Regulation No. 1768/92 EC of 18 June 1992 concerning the creation of a supplementary protection certificate for medicinal products;

– EU Regulation No. 2100/94 EC of 27 July 1994 on Community plant variety rights;

– EU Regulation (EC) 1610/96 of 23 July 1996 concerning the creation of a supplementary protection certificate for plant protection products;

– EU Directive 98/44/EC of 6 July 1998 on the legal protection of biotechnological inventions;

– EU Directive 2004/27/EC of 31 March 2004 amending Directive 2001/83/EC on the Community code relating to medicinal products for human use;

– EU Directive 2004/48/EC of 29 April 2004 on the enforcement of intellectual property rights;

– EU Regulation (EC) No. 1901/2006 of 12 December 2006 on medicinal products for paediatric use;

– EU Regulation (EU) No. 1257/2012 of 17 December 2012 implementing enhanced cooperation in the area of the creation of unitary patent protection (not yet in force);

– EU Regulation (EU) No. 1260/2012 of 17 December 2012 implementing enhanced cooperation in the area of the creation of unitary patent protection with regard to the applicable translation arrangements (not yet in force); and

– Agreement of 19 February 2013 on a Unified Patent Court (not yet in force).

[2] Laws

– Patents Law of 1998 (as amended);

– Patents Rules 1999 (as amended);

– Protection of New Plant Varieties Law No. 21(I)/2004, which took effect in Cyprus on 1 May 2004;

– The Legal Protection of Topographies of Semiconductor Products Law No. 5(I)/2002, as amended by The Legal Protection of Topographies of Semiconductor Products (Amendment) Law of 2006, 120(I)/2006; and

– Law No. 163(I)/2002, The Patents (Amendment) Law of 2002.

[B] Kinds of Patents

– National patents

– European patents.

Depending on ratification of the Agreement on a Unified Patent Court, a European patent granted after the entry into force may, at the applicant's choice, alternatively be registered as a European patent with unitary effect for the whole of the European Union except (as currently expected) Spain and Poland ('EU patent'). See for more details the chapters 'European Union' and 'European Patent System' in the section 'Patents' under 'Conventions and Legislation'.

[C] Duration of Patents

The duration of national patents is twenty years from the filing date of the patent, subject to the payment of annual fees.

[1] Supplementary protection certificate

The term of protection of an invention relating to a pharmaceutical covered by a patent may be extended in Cyprus (by the grant of a supplementary protection certificate) with a period equal to that lapsed between the date of filing the patent application and the date of grant of the first marketing authorization in Cyprus, less five years. The maximum duration of the supplementary protection certificate is five years.

If the first marketing authorization in Cyprus was granted within five years from the date of filing the patent application, no supplementary protection certificate can be obtained. If the first such authorization in Cyprus was granted between five and ten years from the date of filing the patent application, the duration of the certificate may be up to five years, depending on when that authorization was granted. If the first such authorization in Cyprus was granted between ten and twenty years from the date of filing the patent application, a certificate with a duration of five years may be obtained. The period of validity of the certificate runs from the expiration of the basic patent.

The possibility of extension applies both to national Cyprus patents and to European patents valid in Cyprus. Products protected by a patent in Cyprus which, before they may be brought on the market as a medicinal product, are subjected to an administrative authorization procedure in Cyprus, may be the subject of a supplementary protection certificate. Medicinal product in this context means any substance or combination of substances, presented for treating or preventing disease in human beings or animals, and any substance or combination of substances which may be administered to human beings or animals with a view to making a medical diagnosis or to restoring, correcting or modifying physiological functions in human beings or animals. Product in this context means the active ingredient or combination of active ingredients of a medicinal product. For obtaining a supplementary protection certificate, an application must be filed with the Registrar in Cyprus.

Such certificate may be obtained only provided that:

(1) at the date the certificate is applied for the product concerned is protected by a basic patent still in force in Cyprus, which patent protects the product, a process to obtain the product, or an application of the product;

(2) for bringing into the trade of the product concerned as a medicine a valid authorization has been granted in Cyprus;

(3) no previous supplementary protection certificate has been obtained for the product; and

(4) the authorization meant under (2) is the first authorization to put the product on the market in Cyprus as a medicinal product.

A supplementary protection certificate may be applied for by the owner of the basic patent or his or her legal successor or assignee. The certificate must be applied for within six months from the date on which the first marketing authorization for bringing the product concerned on the market as a medicinal product in Cyprus was granted. However, if that authorization was granted before grant of the basic patent, the certificate must be applied for within six months from the date on which the patent is granted.

To continue reading this article, please click here.

Previously published by Kluwer Law International

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Practice Guides
by Mondaq Advice Centres
Relevancy Powered by MondaqAI
United States
Related Topics
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions